Učitavanje...
Parathyroid Hormone Mediates Bone Growth through the Regulation of Osteoblast Proliferation and Differentiation
PTH (1–34) is the only FDA-approved anabolic agent for osteoporosis treatment in the U.S., but its mechanisms are not completely understood. This study investigated PTH effects on osteogenic cells at various stages of differentiation and proliferation using an engineered bone growth model in vivo. O...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2007
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2677418/ https://ncbi.nlm.nih.gov/pubmed/18234576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2007.11.017 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|